- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01331564
eMOMS of Rochester (eMOMS)
November 30, 2015 updated by: Diana Fernandez, University of Rochester
Electronically-Mediated Weight Interventions for Pregnant and Postpartum Women
The project aims to develop, implement and evaluate electronically-mediated behavioral intervention programs for pregnant and postpartum women in order to prevent excessive weight gain during pregnancy and postpartum weight retention.
Study Overview
Status
Completed
Detailed Description
This study seeks to expand the understanding of how to slow the accumulation of weight in childbearing women.
The intervention goals are to decrease the prevalence of excessive pregnancy weight gain and mean weight retention in the first 18 months postpartum in socio-economically and racially/ethnically diverse sample of 1,641 pregnant women.
Women will be randomly assigned to one of three groups: Intervention Group 1 will receive the intervention program only during pregnancy (e-intervention 1).
Intervention Group 2 will receive e-intervention 1 plus intervention for 18 months postpartum (e-intervention 2).
Control women will receive non-weight related content during both time periods at the project website.
The primary hypotheses for the randomized controlled trial are: H1: The proportion of women in Intervention Groups 1 and 2 who gain more weight in pregnancy than is recommended by the IOM will be 33% less than the proportion of the women in the Control Group who gain excessively and H2: The Control Group will have a higher mean weight retention at 12 months postpartum than Intervention Groups 1 and 2.
Study Type
Interventional
Enrollment (Actual)
1641
Phase
- Phase 3
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
New York
-
Rochester, New York, United States, 14642
- University of Rochester
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 35 years (Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- Age 18 - 35 at the time of delivery
- Consented at or before 20 weeks gestation
- Intending to be available for a 24 months intervention
- Plan to deliver in one of the 4 hospitals in Rochester, NY (the study area)
- Plan to carry the pregnancy to term
- Plan to keep the baby
- Read and understand English
Exclusion Criteria:
- BMI < 18.5 kg/m2 and > 35.0 kg/m2.
- Multiple gestation. If multiple gestation is diagnosed after enrollment participant will be terminated from the study (reasons for termination will be included in the consent form)
- Medical conditions prior to pregnancy which could influence weight loss or gain: cystic fibrosis, hyperthyroidism, renal insufficiency1, proteinuria1, cerebral palsy, lupus erythematosus; rheumatoid arthritis, Crohns disease (severity and other autoimmune diseases evaluated case by case), ulcerative colitis, maternal congenital heart disease (patients are often underweight); hypertension treated with medication2,
- Psychiatric medication associated with major weight gain or loss (e.g.; Lithium & Divalproex) Common Criteria
- Household member on study staff
- Past or planned (within the next 24 months) weight loss surgery (e.g. gastric bypass, lap band, or liposuction); current participation in a commercial weight loss program (e.g. Weight Watcher's, Jenny Craig); currently enrolled or planned to enroll in a weight loss or another weight gain prevention study
- Participants will be excluded during screening if they report regular use of systemic steroids, prescription weight loss drugs, and/or diabetes medications (oral or injected- insulin, metformin, byetta, TZDs, other). "Regular use" is defined as "taking this medication most days of the week for the previous month"
- Current treatment for eating disorder
- Positive screening for bulimia
- Weight loss of more than 15 pounds in the three months prior to pregnancy
- Cardiovascular event (heart attack, stroke, episode of heart failure, or revascularization procedure) within the last 6 month. Revascularization is defined as bypass surgery or stints
- Mental or psychiatric condition that precludes giving informed consent and completing questionnaires
- Current treatment for malignancy (other than non-melanoma skin cancer and CIN cervix) or on remission for less than 5 years
- Blood pressure criterion
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Placebo Comparator: Control
|
Control women will receive non-weight related content during both time periods at the project website.
Other Names:
|
|
Experimental: electronic intervention group 2
(e-intervention 2) receives a behavioral intervention through a website during pregnancy and until 18 months postpartum
|
Electronically-mediated behavioral interventions to encourage women to gain an appropriate amount of weight during pregnancy and to follow a healthy lifestyle postpartum to minimize postpartum weight retention
Other Names:
|
|
Experimental: electronic intervention group 1
(e-intervention 1) receives a behavioral intervention through a website during pregnancy.
During the postpartum period this arm receives the same non-weight-related information as the control arm
|
Electronically-mediated behavioral interventions to encourage women to gain an appropriate amount of weight during pregnancy.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Proportion of women whose gestational gain is within the recommended gestational weight gain Institute of Medicine Guidelines in kilograms
Time Frame: 40 weeks
|
Gestational weight gain is the result of the last predelivery weight minus the prepregnancy weight (or early pregnancy weight).
|
40 weeks
|
|
Postpartum weight retention in kg at 12 months postpartum
Time Frame: 1.5 years
|
The difference between the weight at 12 months postpartum and the pre-pregnancy weight (or early pregnancy weight.
Participants will be followed for a maximum of 2 years from recruitment in early pregnancy to 18 months postpartum.
The final outcome in the postpartum period is postpartum weight retention at 18 months.
Interim measure of postpartum weight will be collected at 6 and 12 months for analyses.
The primary hypothesis for the postpartum period is weight retention at 12 months postpartum.
|
1.5 years
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Caloric Intake in Kilocalories
Time Frame: 2 years
|
Caloric intake will be calculated based on the average food intake assessed by 2 24-hour dietary recall.
|
2 years
|
|
Physical activity as an average weekly energy expenditure (METS)
Time Frame: 2 years
|
Physical activity during pregnancy is measured using the Pregnancy Physical Activity Questionnaire and during postpartum using the Global Physical Activity Questionnaire.
|
2 years
|
|
Postpartum weight retention at 18 months
Time Frame: 2 years
|
The difference between the weight at 18 months postpartum and the prepregnancy weight (or early pregnancy weight).
Participants will be followed for a maximum of 2 years from recruitment in early pregnancy to 18 months postpartum.
The final outcome in the postpartum period is postpartum weight retention at 18 months.
Interim measure of postpartum weight will be collected at 6 and 12 months for analyses.
The primary hypothesis for the postpartum period is weight retention at 12 months postpartum
|
2 years
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Isabel D Fernandez, MD, MPH, PhD, University of Rochester
- Principal Investigator: Christine M Olson, PhD, Cornell University
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Yu Y, Ma Q, Fernandez ID, Groth SW. Mental Health, Behavior Change Skills, and Eating Behaviors in Postpartum Women. West J Nurs Res. 2022 Oct;44(10):932-945. doi: 10.1177/01939459211021625. Epub 2021 Jun 4.
- Olson CM, Groth SW, Graham ML, Reschke JE, Strawderman MS, Fernandez ID. The effectiveness of an online intervention in preventing excessive gestational weight gain: the e-moms roc randomized controlled trial. BMC Pregnancy Childbirth. 2018 May 9;18(1):148. doi: 10.1186/s12884-018-1767-4.
- Olson CM, Strawderman MS, Graham ML. Association between consistent weight gain tracking and gestational weight gain: Secondary analysis of a randomized trial. Obesity (Silver Spring). 2017 Jul;25(7):1217-1227. doi: 10.1002/oby.21873. Epub 2017 Jun 2.
- Graham ML, Strawderman MS, Demment M, Olson CM. Does Usage of an eHealth Intervention Reduce the Risk of Excessive Gestational Weight Gain? Secondary Analysis From a Randomized Controlled Trial. J Med Internet Res. 2017 Jan 9;19(1):e6. doi: 10.2196/jmir.6644.
- Fernandez ID, Groth SW, Reschke JE, Graham ML, Strawderman M, Olson CM. eMoms: Electronically-mediated weight interventions for pregnant and postpartum women. Study design and baseline characteristics. Contemp Clin Trials. 2015 Jul;43:63-74. doi: 10.1016/j.cct.2015.04.013. Epub 2015 May 6.
- Demment MM, Graham ML, Olson CM. How an online intervention to prevent excessive gestational weight gain is used and by whom: a randomized controlled process evaluation. J Med Internet Res. 2014 Aug 20;16(8):e194. doi: 10.2196/jmir.3483.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
May 1, 2011
Primary Completion (Actual)
May 1, 2014
Study Completion (Actual)
December 1, 2014
Study Registration Dates
First Submitted
March 31, 2011
First Submitted That Met QC Criteria
April 6, 2011
First Posted (Estimate)
April 8, 2011
Study Record Updates
Last Update Posted (Estimate)
December 2, 2015
Last Update Submitted That Met QC Criteria
November 30, 2015
Last Verified
November 1, 2015
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- HL096760
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Gestational Weight Gain
-
Andalas UniversityNational Institute of Health Research and Development, Ministry of Health...CompletedBirth Weight | Pregnancy Weight GainIndonesia
-
University of Colorado, DenverEunice Kennedy Shriver National Institute of Child Health and Human Development...Completed
-
T.C. ORDU ÜNİVERSİTESİEge UniversityCompletedGestational Weight GainTurkey
-
University of HawaiiCompletedGestational Weight GainUnited States
-
Helena PiccininiNova Scotia Health AuthorityWithdrawnGestational Weight GainCanada
-
West China HospitalWest China Second University HospitalCompleted
-
International Centre for Diarrhoeal Disease Research...Obstetrical and Gynaecological Society of Bangladesh (OGSB)Active, not recruiting
-
Seda ÇETİN AVCIActive, not recruiting
-
Arizona State UniversityKripalu Center for Yoga and HealthCompletedWeight GainUnited States
Clinical Trials on electronic intervention during pregnancy and postpartum
-
KK Women's and Children's HospitalCompletedTransfusion; Maternofetal
-
Odense University HospitalCompleted
-
University of Rome G. MarconiUniversity of Bologna; University of the Italian SwitzerlandRecruitingStress | Insomnia | Postpartum DepressionItaly
-
University of PittsburghNational Institute on Drug Abuse (NIDA)CompletedPregnancy Related | Opioid-use DisorderUnited States
-
Tufts UniversityCompletedPregnancy | Overweight and ObesityUnited States
-
Semra YILMAZCompletedPostpartum Smoking RelapseTurkey
-
Hospices Civils de LyonCompleted
-
University of ManitobaCompletedPerinatal Depression | Perinatal AnxietyCanada
-
Instituto de Nutrición y Tecnología de los AlimentosPontificia Universidad Catolica de Chile; Servicio de Salud Metropolitano Sur...Active, not recruitingNutritional Status | Body Composition | Breast Density | Mental Health IssueChile
-
Universidad de GranadaCompletedHypertension | Obesity | Pregnancy | Gestational DiabetesSpain